Published in Health Qual Life Outcomes on April 28, 2003
Treatment With AKL1 in Obstructive Airways Disease (The TAKL Study) (TAKL) | NCT00920127
Adherence Study in COPD Patients | NCT02864342
Simvastatin in Chronic Obstructive Pulmonary Disease (COPD) | NCT00680641
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med (2016) 5.23
Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res (2006) 2.03
Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res (2008) 1.98
A Wireless Health Outcomes Monitoring System (WHOMS): development and field testing with cancer patients using mobile phones. BMC Med Inform Decis Mak (2004) 1.72
New GOLD classification: longitudinal data on group assignment. Respir Res (2014) 1.64
Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc (2007) 1.63
Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med (2011) 1.54
Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52
Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis (2012) 1.47
Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes (2009) 1.43
Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One (2014) 1.23
Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis (2011) 1.10
Health status in routine clinical practice: validity of the clinical COPD questionnaire at the individual patient level. Health Qual Life Outcomes (2010) 1.10
COPD management: role of symptom assessment in routine clinical practice. Int J Chron Obstruct Pulmon Dis (2013) 1.09
Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 1.08
Validation of the Clinical COPD questionnaire in Italian language. Health Qual Life Outcomes (2005) 1.08
Patient-reported outcome measures in inflammatory bowel disease. Can J Gastroenterol Hepatol (2014) 1.07
Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J Chron Obstruct Pulmon Dis (2009) 1.04
Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PLoS One (2012) 1.04
Assessment of COPD wellness tools for use in primary care: an IPCRG initiative. Int J Chron Obstruct Pulmon Dis (2012) 1.04
Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument. Qual Life Res (2009) 1.01
Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT. Eur J Nucl Med Mol Imaging (2011) 0.99
Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax (2014) 0.98
Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: an evaluation of the underlying concepts of this questionnaire. Respir Res (2010) 0.98
Clinical COPD Questionnaire score (CCQ) and mortality. Int J Chron Obstruct Pulmon Dis (2012) 0.96
Flow-Volume Parameters in COPD Related to Extended Measurements of Lung Volume, Diffusion, and Resistance. Pulm Med (2013) 0.96
Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study. BMC Pulm Med (2014) 0.95
Symptom variability in COPD: a narrative review. Int J Chron Obstruct Pulmon Dis (2013) 0.95
Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2009) 0.92
Predictors of ICS/LABA prescribing in COPD patients: a study from general practice. BMC Fam Pract (2014) 0.92
Assessing the Impact of Tiotropium on Lung Function and Physical Activity in GOLD Stage II COPD Patients who are Naïve to Maintenance Respiratory Therapy: A Study Protocol. Open Respir Med J (2011) 0.91
Action Plan to enhance self-management and early detection of exacerbations in COPD patients; a multicenter RCT. BMC Pulm Med (2009) 0.91
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre study. Respir Res (2009) 0.91
Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract (2009) 0.91
Perceived quality of life in chronic obstructive pulmonary disease patients: a cross-sectional study in primary care on the role of illness perceptions. BMC Fam Pract (2014) 0.91
Application of a theoretical model to evaluate COPD disease management. BMC Health Serv Res (2010) 0.90
Daily activities and health-related quality of life in patients with chronic obstructive pulmonary disease: psychological determinants: a cross-sectional study. Health Qual Life Outcomes (2013) 0.90
Smoking cessation can improve quality of life among COPD patients: validation of the clinical COPD questionnaire into Greek. BMC Pulm Med (2011) 0.90
Palliative care or end-of-life care in advanced chronic obstructive pulmonary disease: a prospective community survey. Br J Gen Pract (2011) 0.90
Validity of instruments to measure physical activity may be questionable due to a lack of conceptual frameworks: a systematic review. Health Qual Life Outcomes (2011) 0.90
Integration of healthcare rehabilitation in chronic conditions. Int J Integr Care (2010) 0.90
Putting health status guided COPD management to the test: protocol of the MARCH study. BMC Pulm Med (2013) 0.89
A comprehensive systematic review of the development process of 104 patient-reported outcomes (PROs) for physical activity in chronically ill and elderly people. Health Qual Life Outcomes (2011) 0.88
COPD exacerbations. 4: Prevention. Thorax (2006) 0.88
Feasibility and effectiveness of an asthma/COPD service for primary care: a cross-sectional baseline description and longitudinal results. NPJ Prim Care Respir Med (2015) 0.88
Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.88
RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care. BMC Pulm Med (2013) 0.87
Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes (2010) 0.87
Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care. Int J Chron Obstruct Pulmon Dis (2017) 0.87
Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease. Respir Res (2012) 0.86
Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcomes (2013) 0.86
Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial. BMC Public Health (2010) 0.86
Patient-reported physical activity questionnaires: a systematic review of content and format. Health Qual Life Outcomes (2012) 0.86
Integrating a tailored e-health self-management application for chronic obstructive pulmonary disease patients into primary care: a pilot study. BMC Fam Pract (2014) 0.86
PROLONG: a cluster controlled trial to examine identification of patients with COPD with poor prognosis and implementation of proactive palliative care. BMC Pulm Med (2014) 0.85
Change in health status in long-term conditions over a one year period: a cohort survey using patient-reported outcome measures. Health Qual Life Outcomes (2014) 0.84
Early telemedicine training and counselling after hospitalization in patients with severe chronic obstructive pulmonary disease: a feasibility study. BMC Med Inform Decis Mak (2015) 0.84
The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial. PLoS One (2014) 0.84
Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care. BMC Pulm Med (2014) 0.83
Early assisted discharge with generic community nursing for chronic obstructive pulmonary disease exacerbations: results of a randomised controlled trial. BMJ Open (2012) 0.83
Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD. NPJ Prim Care Respir Med (2014) 0.83
Evaluation of smoking-specific and generic quality of life measures in current and former smokers in Germany and the United States. Health Qual Life Outcomes (2015) 0.82
A randomised controlled trial testing a web-based, computer-tailored self-management intervention for people with or at risk for chronic obstructive pulmonary disease: a study protocol. BMC Public Health (2013) 0.82
Should chest examination be reinstated in the early diagnosis of chronic obstructive pulmonary disease? Int J Chron Obstruct Pulmon Dis (2013) 0.82
The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.82
The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients: a protocol for an UNLOCK study from the IPCRG. NPJ Prim Care Respir Med (2016) 0.82
Health status measured by the Clinical COPD Questionnaire (CCQ) improves following post-acute pulmonary rehabilitation in patients with advanced COPD: a prospective observational study. NPJ Prim Care Respir Med (2014) 0.82
Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics. Eur Clin Respir J (2016) 0.81
A randomized controlled trial evaluating the effectiveness of a web-based, computer-tailored self-management intervention for people with or at risk for COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation. Int J Chron Obstruct Pulmon Dis (2015) 0.81
A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis (2015) 0.81
The clinical chronic obstructive pulmonary disease questionnaire: cut point for GOLD 2013 classification. Am J Respir Crit Care Med (2014) 0.81
Depression and heart failure associated with clinical COPD questionnaire outcome in primary care COPD patients: a cross-sectional study. NPJ Prim Care Respir Med (2014) 0.81
COPD: the patient perspective. Int J Chron Obstruct Pulmon Dis (2016) 0.81
A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study. Int J Chron Obstruct Pulmon Dis (2015) 0.81
The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis (2014) 0.80
Utility of brief questionnaires of health-related quality of life (Airways Questionnaire 20 and Clinical COPD Questionnaire) to predict exacerbations in patients with asthma and COPD. Health Qual Life Outcomes (2013) 0.80
Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocol. BMC Pulm Med (2015) 0.79
Cigarette and waterpipe smoking decrease respiratory quality of life in adults: results from a national cross-sectional study. Pulm Med (2012) 0.79
The clinical COPD questionnaire correlated with BODE index-A cross-sectional study. ScientificWorldJournal (2012) 0.79
Is 'GOLD' standard for the management of COPD in clinical practice? Drugs Context (2012) 0.79
Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial. Clin Transl Med (2014) 0.79
Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2011) 0.78
Health-related quality of life in chronic obstructive pulmonary disease patients in Korea. Health Qual Life Outcomes (2014) 0.78
Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations. BMJ Open Respir Res (2014) 0.78
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial. BMC Public Health (2007) 0.78
Time pressured deprioritization of COPD in primary care: a qualitative study. Scand J Prim Health Care (2016) 0.77
Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. Patient Prefer Adherence (2015) 0.77
A short questionnaire for the assessment of quality of life in patients with chronic obstructive pulmonary disease: psychometric properties of VQ11. Health Qual Life Outcomes (2013) 0.77
Does the duration of smoking cessation have an impact on hospital admission and health-related quality of life amongst COPD patients? Int J Chron Obstruct Pulmon Dis (2014) 0.77
Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Grading obstructive lung disease using tomographic pulmonary scintigraphy in patients with chronic obstructive pulmonary disease (COPD) and long-term smokers. Ann Nucl Med (2014) 0.77
Design, rationale, and baseline demographics of SEARCH I: a prospective cluster-randomized study. Int J Chron Obstruct Pulmon Dis (2012) 0.77
Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial. BMJ Open (2015) 0.76
Physical Activity Characteristics across GOLD Quadrants Depend on the Questionnaire Used. PLoS One (2016) 0.76
The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study. Drug Alcohol Depend (2015) 0.76
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92
A measure of quality of life for clinical trials in chronic lung disease. Thorax (1987) 10.87
Development and validation of a questionnaire to measure asthma control. Eur Respir J (1999) 9.35
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J (1995) 7.03
Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med (2001) 4.48
A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest (2002) 2.74
Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.52
The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med (2001) 1.96
Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J (1994) 1.91
Quality of life measurement for patients with diseases of the airways. Thorax (1991) 1.88
Issues concerning health-related quality of life in COPD. Chest (1995) 1.64
Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med (2011) 6.89
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. Chest (2007) 2.96
Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest (2012) 2.77
Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet (2001) 2.61
A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet (2012) 2.60
Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation. N Engl J Med (2015) 2.59
Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med (2003) 2.45
Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies. Lancet (2007) 2.41
Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol (2011) 2.39
Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA. J Allergy Clin Immunol (2011) 2.38
Overweight and changes in weight status during childhood in relation to asthma symptoms at 8 years of age. J Allergy Clin Immunol (2009) 2.37
Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight. Nat Genet (2010) 2.30
CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax (2011) 2.20
Symptom-based questionnaire for identifying COPD in smokers. Respiration (2005) 2.18
Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol (2007) 2.18
Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels. FASEB J (2013) 2.16
Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet (2009) 2.15
Clinical control of asthma associates with measures of airway inflammation. Thorax (2012) 2.15
Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 2.10
Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet (2012) 2.09
A critical look at transition ratings. J Clin Epidemiol (2002) 2.08
Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med (2006) 2.05
Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med (2009) 2.04
Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet (2004) 2.03
The Asthma-COPD Overlap Syndrome. N Engl J Med (2015) 1.99
Blood pressure in 12-year-old children is associated with fatty acid composition of human milk: the prevention and incidence of asthma and mite allergy birth cohort. Hypertension (2012) 1.97
Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1). Am J Respir Crit Care Med (2002) 1.92
New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet (2012) 1.90
Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease. Thorax (2012) 1.88
Small airway disease in asthma and COPD: clinical implications. Chest (2011) 1.86
A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population. Am J Respir Crit Care Med (2005) 1.82
Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol (2009) 1.82
Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med (2014) 1.80
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest (2007) 1.79
A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur J Hum Genet (2010) 1.74
A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med (2013) 1.73
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD. Eur Respir J (2012) 1.71
Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2009) 1.70
Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J Allergy Clin Immunol (2003) 1.69
Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. Atherosclerosis (2013) 1.69
Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol (2006) 1.69
Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control. Chest (2008) 1.67
First study of infliximab treatment in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.64
Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids. Am J Respir Crit Care Med (2014) 1.62
Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. J Proteome Res (2009) 1.59
Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results. Chest (2011) 1.53
Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet (2012) 1.52
An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.51
Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol (2002) 1.50
Molecular signature of smoking in human lung tissues. Cancer Res (2012) 1.50
Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med (2012) 1.49
Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction. Respir Med (2004) 1.48
Major recessive gene(s) with considerable residual polygenic effect regulating adult height: confirmation of genomewide scan results for chromosomes 6, 9, and 12. Am J Hum Genet (2002) 1.47
Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses. Am J Respir Crit Care Med (2015) 1.44
Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship. Transplantation (2006) 1.44
Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res (2006) 1.44
Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology (2014) 1.44
Symptom-based questionnaire for differentiating COPD and asthma. Respiration (2005) 1.43
Sex differences in asthma during the first 8 years of life: the Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort study. J Allergy Clin Immunol (2010) 1.43
Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler. Respirology (2013) 1.38
Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease. Respir Med (2004) 1.37
ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res (2005) 1.37
The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. Am J Respir Crit Care Med (2009) 1.36
Identification of PCDH1 as a novel susceptibility gene for bronchial hyperresponsiveness. Am J Respir Crit Care Med (2009) 1.35
Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. Chest (2005) 1.33
The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: a pilot study. Patient Educ Couns (2006) 1.29
More alternative activation of macrophages in lungs of asthmatic patients. J Allergy Clin Immunol (2010) 1.28
Association of IL1RL1, IL18R1, and IL18RAP gene cluster polymorphisms with asthma and atopy. J Allergy Clin Immunol (2008) 1.27
Cognitive performance in patients with COPD. Respir Med (2004) 1.26
Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir Res (2005) 1.25
Expression of ADAMs ("a disintegrin and metalloprotease") in the human lung. Virchows Arch (2009) 1.24
Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes. Am J Respir Crit Care Med (2008) 1.21
Are there reasons why adult asthma is more common in females? Curr Allergy Asthma Rep (2007) 1.21
Gender differences in asthma development and remission during transition through puberty: the TRacking Adolescents' Individual Lives Survey (TRAILS) study. J Allergy Clin Immunol (2010) 1.21
Genome-wide association study of lung function decline in adults with and without asthma. J Allergy Clin Immunol (2012) 1.20
Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol (2005) 1.19
House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium. Am J Respir Cell Mol Biol (2009) 1.18
Interleukin 13 and interleukin 4 receptor-α polymorphisms in rhinitis and asthma. Int Arch Allergy Immunol (2010) 1.17
Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β₁ is increased in chronic obstructive pulmonary disease. PLoS One (2011) 1.16
Cohort profile: the prevention and incidence of asthma and mite allergy (PIAMA) birth cohort. Int J Epidemiol (2013) 1.15
Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respir Res (2007) 1.13
Increased systemic inflammation is a risk factor for COPD exacerbations. Chest (2008) 1.12
Short-term smoke exposure attenuates ovalbumin-induced airway inflammation in allergic mice. Am J Respir Cell Mol Biol (2004) 1.12
Retracted Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all? Naunyn Schmiedebergs Arch Pharmacol (2008) 1.12
Noncanonical WNT-5A signaling regulates TGF-β-induced extracellular matrix production by airway smooth muscle cells. FASEB J (2012) 1.11
Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.10
E-cadherin: gatekeeper of airway mucosa and allergic sensitization. Trends Immunol (2011) 1.09
Identification of polymorphisms in the human glucocorticoid receptor gene (NR3C1) in a multi-racial asthma case and control screening panel. DNA Seq (2004) 1.09
Variants of the FADS1 FADS2 gene cluster, blood levels of polyunsaturated fatty acids and eczema in children within the first 2 years of life. PLoS One (2010) 1.09